Soomekh David J
University Foot and Ankle Institute, 2121 Wilshire Boulevard, #101 Santa Monica, CA 90403, USA.
Clin Podiatr Med Surg. 2011 Jan;28(1):155-70. doi: 10.1016/j.cpm.2010.09.001.
Platelet-rich plasma (PRP) injections have been used and studied since the 1970s. Its use has become more popularized over the last several years in the treatment of foot and ankle injuries. Platelets are a normal product found in the clotting cascade and inflammatory process of healing. They produce granules that release growth factors that promote healing. PRP works by increasing the concentration of platelets, thereby increasing the concentration of growth factors and increasing healing potential. PRP has an advantage over many tissue engineering products in that it is autologous. It has been studied and used for the treatment of tendon injuries, chronic wounds, ligamentous injuries, cartilage injuries, muscle injuries, and bone augmentation. The results from in vitro and in vivo studies in foot and ankle injuries are promising. The applications for treatment in the foot and ankle may be broader than once thought.
自20世纪70年代以来,富含血小板血浆(PRP)注射疗法就已被应用和研究。在过去几年中,其在足踝损伤治疗中的应用越来越普遍。血小板是凝血级联反应和愈合炎症过程中的一种正常产物。它们产生能释放促进愈合的生长因子的颗粒。PRP通过增加血小板浓度起作用,从而提高生长因子浓度并增强愈合潜能。与许多组织工程产品相比,PRP的优势在于它是自体的。它已被研究并用于治疗肌腱损伤、慢性伤口、韧带损伤、软骨损伤、肌肉损伤和骨增量。足踝损伤的体外和体内研究结果很有前景。足踝治疗的应用范围可能比以往认为的更广。